Chief Executive Officer
CurrentDeveloping next-gen therapies for the management of diabetes and obesity
Please complete the CAPTCHA to continue
A concise factual answer block for searchers comparing this professional profile.
Ryan Lafferty is listed as Chief Executive Officer @ Dia Beta Labs Ltd at Dia Beta Labs Ltd, based in Belfast Metropolitan Area, United Kingdom. AeroLeads shows a matched LinkedIn profile for Ryan Lafferty.
Ryan Lafferty previously worked as Chief Executive Officer at Dia Beta Labs Ltd and Postdoctoral Research Associate at Ulster University. Ryan Lafferty holds Doctor Of Philosophy - Phd, Biomedical Sciences, General from Ulster University.
This section adds company-level context without repeating Ryan Lafferty's masked contact details.
Review company-level records connected to Ryan Lafferty before choosing the right outreach path.
Community pharmacist, turned scientist. Scientist, turned entrepreneur.PhD | MPharm | Chief Executive Officer @ Dia Beta Labs Ltd | Aiming to transform standards of care in diabetes management |Researchgate: https://bit.ly/2R6Bodt | Twitter (@RA_Lafferty): https://bit.ly/2TCNFHF | https://diabetalabs.com |
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Coleraine, Gb
Developing next-gen therapies for the management of diabetes and obesity
Northern Ireland, Gb
Currently a collaborator on the "MaraBioactive: Extraction and exploitation of bioactive fish components for health enhancement" project at Ulster University in partnership University College Cork (UCC), University of Limerick (UL) and Galway Mayo Institute of Technology (GMIT). The project aims to investigate the development of reproducible and scalable protocols for the generation of prototype blue whiting biofunctional peptide ingredients with a potential role in the modulation of obesity-diabetes.
Northern Ireland, Gb
PhD Student within the Diabetes Research Group at UUC exploring the therapeutic potential of novel Peptide YY based analogues in diabetes and obesity
Enrolled on the prestigious Innovation to Commercialisation of University Research (ICURe) programme on behalf of the Diabetes Research Group at Ulster University. I guided the team through a 3 month market discovery period after which I presented findings to a panel of industry experts at the "Options Roundabout" who validated our suitability to pursue spin-out. Following success at the Options Roundabout, we were granted additional funding to build our business case and put together an application for follow-on funding from Innovate UK. Again, I was able to lead the team towards success, with over £297,000 awarded provisionally to our spin-out.
Thousand Oaks, Ca, Us
Tweeting on behalf of two SAGE, open access journals; "Therapeutic Advances in Endocrinology and Metabolism" and "Clinical Medicine Insights: Endocrinology and Diabetes" to promote articles and engage with readership
Belfast, N. Ireland, Gb
Following completion of my Pre-Registration year at a Medicare branch in West Belfast, I continued to work regularly as a locum pharmacist in the Greater Belfast area; working as part of various teams across several branches.
Livonia, Michigan, Us
I worked with Hygieia on a part-time basis (in addition to continuing my work as a locum pharmacist). This saw me working as part of a multi-disciplinary team (consisting of doctors, nurses and another pharmacist) to provide a support service for Type 1 and Type 2 diabetics using the d-Nav insulin-guidance device. This involved me enrolling patients onto the service (which required intensive counselling regarding the device, service and medicines – particularly for those new to insulin therapy), following up patients to determine their progress (through interpreting device downloads and testing HbA1c) and also liaising with a patient’s relevant health-care professionals should any issues or concerns regarding their diabetic control arise.
Quick answers generated from the profile data available on this page.
Ryan Lafferty works for Dia Beta Labs Ltd.
Ryan Lafferty is listed as Chief Executive Officer @ Dia Beta Labs Ltd at Dia Beta Labs Ltd.
Ryan Lafferty is based in Belfast Metropolitan Area, United Kingdom while working with Dia Beta Labs Ltd.
Ryan Lafferty has worked for Dia Beta Labs Ltd, Ulster University, Dia Beta Labs, Sage Publishing, and Medicare Pharmacy Group (Ni).
You can use AeroLeads to view verified contact signals for Ryan Lafferty at Dia Beta Labs Ltd, including work email, phone, and LinkedIn data when available.
Ryan Lafferty holds Doctor Of Philosophy - Phd, Biomedical Sciences, General from Ulster University.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts